How Much Did Kindbody Raise? Funding & Key Investors

Date
March 31, 2025
Kindbody

Total amount raised

$306.3 Millions

Latest funding date

Kindbody

Location

Title

LINKEDIN

https://www.crunchbase.com/organization/kindbody/financial_details
Use Clay to find other emails
Status
Verified
Use Clay's email finder to get anyone's work email in seconds.

Kindbody has successfully raised significant funding across multiple rounds, attracting a diverse group of investors. The company is dedicated to providing comprehensive fertility and family-building care through a modern, tech-enabled platform.

Continue reading to delve into the details of Kindbody's funding journey and the investors who are supporting this innovative healthcare provider.

What Is Kindbody?

Kindbody, founded in 2018 by Gina Bartasi and Joanne Schneider, is a fertility clinic network based in New York, New York. The company specializes in providing comprehensive fertility and family-building care through both virtual and in-person services.

Kindbody offers a wide range of services, including fertility assessments, IVF, egg freezing, genetic testing, and surrogacy. They also partner with employers to provide fertility benefits, ensuring financial, medical, and emotional support for employees.

With a team of 501-1000 employees, Kindbody is dedicated to modernizing fertility care and making it accessible to a broader audience through tech-enabled solutions.

How Much Funding Has Kindbody Raised?

  1. Seed Round
    • Amount Raised: $2.1M
    • Date: February 2018
    • Lead Investors: Not publicly disclosed
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: Initial funding to launch the company and develop its tech-enabled fertility services.
  2. Seed Round
    • Amount Raised: $4.2M
    • Date: August 2018
    • Lead Investors: Marco DeMeireles
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: To expand initial operations and build out the clinic network.
  3. Series A
    • Amount Raised: $15M
    • Date: April 2019
    • Lead Investors: Perceptive Advisors, RRE Ventures
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: To scale operations and enhance service offerings.
  4. Series A
    • Amount Raised: $10M
    • Date: December 2019
    • Lead Investors: Google Ventures
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: To further expand clinic locations and improve technology infrastructure.
  5. Series B
    • Amount Raised: $32M
    • Date: July 2020
    • Lead Investors: Perceptive Advisors
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: To support rapid growth and expand into new markets.
  6. Series C
    • Amount Raised: $62M
    • Date: June 2021
    • Lead Investors: Claritas Health Ventures
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: To enhance service offerings and expand the clinic network.
  7. Venture Round
    • Amount Raised: $29.4M
    • Date: March 2022
    • Lead Investors: Not publicly disclosed
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: To continue scaling operations and invest in technology.
  8. Series C
    • Amount Raised: $26.7M
    • Date: September 2022
    • Lead Investors: Not publicly disclosed
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: To support further expansion and enhance service delivery.
  9. Debt Financing
    • Amount Raised: $100M
    • Date: March 2023
    • Lead Investors: Perceptive Advisors
    • Valuation at Round: $1.8 billion
    • Motivation Behind the Round: To expand fertility services into new markets and open 10 new locations.
  10. Venture Round
    • Amount Raised: $25M
    • Date: May 2023
    • Lead Investors: Morgan Health
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: To continue expanding and enhancing fertility services.

Total Amount Raised: $306.4M. Current Valuation: $1.8 billion.

Key Investors

  • Perceptive Advisors
    • Details: Perceptive Advisors is a leading investment management firm focused on the healthcare sector. They have a strong track record in life sciences investments.
    • Investment Focus Areas: Biotechnology, pharmaceuticals, medical devices, healthcare services.
    • Notable Investments: Not publicly disclosed.
  • GV (formerly Google Ventures)
    • Details: GV is the venture capital investment arm of Alphabet Inc., focusing on funding innovative startups. They have a diverse portfolio across various sectors.
    • Investment Focus Areas: Technology, life sciences, healthcare.
    • Notable Investments: Uber, Slack, Flatiron Health.
  • RRE Ventures
    • Details: RRE Ventures is a venture capital firm that invests in early-stage companies. They are known for supporting innovative technology startups.
    • Investment Focus Areas: Technology, innovation across various sectors.
    • Notable Investments: BuzzFeed, Venmo, Spaceflight Industries.
  • Claritas Health Ventures
    • Details: Claritas Health Ventures is a venture capital firm focused on healthcare investments. They aim to support companies that improve healthcare delivery and outcomes.
    • Investment Focus Areas: Healthcare, life sciences.
    • Notable Investments: Not publicly disclosed.
  • Morgan Health
    • Details: Morgan Health is an investment arm focused on improving healthcare outcomes. They invest in companies that offer innovative healthcare solutions.
    • Investment Focus Areas: Not publicly disclosed.
    • Notable Investments: Not publicly disclosed.

What's Next for Kindbody?

Kindbody is poised to capitalize on the growing demand for fertility services by expanding into new markets with 10 additional locations. This expansion is driven by the increasing importance of fertility benefits among employers and the rising number of women requiring medical support to conceive. With a valuation of $1.8 billion and a strong investor base, the company is well-positioned to continue its growth trajectory.

Future fundraising opportunities are likely as Kindbody aims to become EBITDA and cash flow positive, potentially paving the way for an IPO. However, the company will need to navigate challenges such as high treatment costs, competition from other fertility service providers, and maintaining high-quality care during rapid expansion. The fertility market's growth and technological advancements present both opportunities and hurdles for Kindbody's ambitious plans.

Use Clay to Get Funding Data

Sales professionals, take your strategy to the next level by leveraging Clay’s platform to access comprehensive fundraising data on companies like Kindbody and gather other critical business insights.

Sign up for free on Clay and start making data-driven decisions today.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

Try for free

More Articles